MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
3.610
-0.180 (-4.75%)
At close: May 21, 2026, 4:00 PM EDT
3.650
+0.040 (1.11%)
After-hours: May 21, 2026, 7:02 PM EDT

MiMedx Group Revenue

MiMedx Group had revenue of $58.99M in the quarter ending March 31, 2026, a decrease of -33.12%. This brings the company's revenue in the last twelve months to $389.42M, up 10.51% year-over-year. In the year 2025, MiMedx Group had annual revenue of $418.63M with 19.99% growth.

Revenue (ttm)
$389.42M
Revenue Growth
+10.51%
P/S Ratio
1.38
Revenue / Employee
$481,950
Employees
808
Market Cap
537.69M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025418.63M69.75M19.99%
Dec 31, 2024348.88M27.40M8.52%
Dec 31, 2023321.48M53.64M20.03%
Dec 31, 2022267.84M25.82M10.67%
Dec 31, 2021242.02M-6.22M-2.50%
Dec 31, 2020248.23M-51.02M-17.05%
Dec 31, 2019299.26M-59.86M-16.67%
Dec 31, 2018359.11M37.97M11.82%
Dec 31, 2017321.14M99.43M44.85%
Dec 31, 2016221.71M34.42M18.38%
Dec 31, 2015187.30M69.07M58.43%
Dec 31, 2014118.22M59.04M99.77%
Dec 31, 201359.18M32.13M118.76%
Dec 31, 201227.05M19.29M248.60%
Dec 31, 20117.76M6.97M883.74%
Dec 31, 2010788.87K--
Mar 31, 2009---
Mar 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Rigel Pharmaceuticals299.77M
Valneva SE180.25M
Ginkgo Bioworks Holdings151.40M
XOMA Royalty48.56M
Prime Medicine4.03M
ProKidney889.00K
Revenue Rankings